GTF3C2 Promotes the Proliferation of Hepatocellular Carcinoma Cells through the USP21/MEK2/ERK1/2 Pathway
Yani Wu, Yingnan Yang, Youju Zhang, Qiuran Xu, Dongsheng Huang, Kangsheng Tu
doi:10.14218/JCTH.2024.00386
Beyond the Cure: Navigating Hepatocellular Risk and Surveillance after Hepatitis C Eradication in the Direct-acting Antiviral Era
Chencheng Xie, Ashwani K. Singal
doi:10.14218/JCTH.2024.00499
The Role of Solute Carrier Family Transporters in Hepatic Steatosis and Hepatic Fibrosis
Chi Zhang, Xuanran Yang, Yi Xue, Huan Li, Chuanfei Zeng, Mingkai Chen
[ Html ]
[ PDF ] 233-252
doi:10.14218/JCTH.2024.00348
The Impact of Liver Graft Preservation Method on Longitudinal Gut Microbiome Changes Following Liver Transplant: A Proof-of-concept Study
Gail A.M. Cresci, Qiang Liu, Naseer Sangwan, Darren Liu, David Grove, David Shapiro, Khaled Ali, Beatrice Cazzaniga, Luca Del Prete, Charles Miller, Koji Hashimoto, Cristiano Quintini
[ Html ]
[ PDF ] 284-294
doi:10.14218/JCTH.2024.00352
Ursodeoxycholic Acid for the Management of Drug-induced Liver Injury: Role of Hepatoprotective and Anti-cholestatic Mechanisms
Fernando Bessone, Geraldine L. Hillotte, Norberto Tamagnone, Daiana Arnedillo, Marcelo G. Roma
[ Html ]
[ PDF ] 162-168
doi:10.14218/JCTH.2024.00325
Liver Injury in Immune Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Five New Classification Types
Rolf Teschke
[ Html ]
[ PDF ] 339-357
doi:10.14218/JCTH.2024.00402
Patients with AMA/anti-sp100/anti-gp210 Positivity and Cholestasis Can Manifest Conditions Beyond Primary Biliary Cholangitis
Xin Zeng, Tingting Lv, Shuxiang Li, Sha Chen, Buer Li, Zhijiao Lu, Yu Wang, Xiaojuan Ou, Xinyan Zhao, Hong You, Weijia Duan, Jidong Jia
[ Html ]
[ PDF ] 200-206
doi:10.14218/JCTH.2024.00374
Unraveling the Role of the Wnt Pathway in Hepatocellular Carcinoma: From Molecular Mechanisms to Therapeutic Implications
Zixin Liang, Shanshan Li, Zhiyu Wang, Junting Zhou, Ziyue Huang, Jiehan Li, Haolin Bao, Judy Wai Ping Yam, Yi Xu
[ Html ]
[ PDF ] 315-326
doi:10.14218/JCTH.2024.00401
Significant Response to Palbociclib Plus Lenvatinib as Second-line Treatment for CDKN2A/2B Deletion Intrahepatic Cholangiocarcinoma: A Case Report
Kai Liu, Ziyue Huang, Lijin Zhao, Haitao Zhao
[ Html ]
[ PDF ] 169-172
doi:10.14218/JCTH.2024.00404
Fluorescence-guided Surgery for Hepatocellular Carcinoma: From Clinical Practice to Laboratories
Tian Xiao, Didi Chen, Li Peng, Zhuoxia Li, Wenming Pan, Yuping Dong, Jinxiang Zhang, Min Li
[ Html ]
[ PDF ] 216-232
doi:10.14218/JCTH.2024.00375
Effectiveness and Safety of Tenofovir Amibufenamide in the Treatment of Chronic Hepatitis B: A Real-world, Multicenter Study
Yaping Li, Yongmei Lin, Guoe Gou, Dandan Cui, Xiaohong Gao, Guanghua Xu, Hongmei Zu, Shuangsuo Dang
[ Html ]
[ PDF ] 207-215
doi:10.14218/JCTH.2024.00364